Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-43.2%
5Y CAGR+18.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-43.2%/yr
Annual compound
5Y CAGR
+18.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $453.91M | -39.3% |
| 2024 | $748.25M | -29.5% |
| 2023 | $1.06B | -57.2% |
| 2022 | $2.48B | +23.3% |
| 2021 | $2.01B | +916.1% |
| 2020 | $198.07M | +57.5% |
| 2019 | $125.78M | - |